AI Stock Income Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Income Statements
Quarterly
|
Annual
Unit: USD | 2025-01-01 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 | 2018-12-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2016-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
asu no. 2016-01, recognition and measurement of financial assets and financial liabilities | ||||||||||||
asu no. 2016-02, leases | ||||||||||||
standard | ||||||||||||
asu no. 2016-13, financial instruments - credit losses | ||||||||||||
asu no. 2016-15, classification of certain cash receipts and cash payments | ||||||||||||
asu no. 2017-8, premium amortization of purchased callable debt securities | ||||||||||||
net gains recognized in earnings for: | ||||||||||||
agency mbs still held at period end | ||||||||||||
agency mbs sold during the period | ||||||||||||
total | 5,546,000 | |||||||||||
beginning balance | 1,799,000 | |||||||||||
accretion | ||||||||||||
reclassifications | ||||||||||||
eliminations in consolidation | ||||||||||||
sales | ||||||||||||
ending balance | 1,976,000 | |||||||||||
cumulative credit related other-than-temporary impairments, beginning balance | ||||||||||||
additions for: | ||||||||||||
securities for which other-than-temporary impairments have not previously occurred | ||||||||||||
securities with previously recognized other-than- temporary impairments | ||||||||||||
reductions for sold or matured securities | ||||||||||||
cumulative credit related other-than-temporary impairments, ending balance | ||||||||||||
private-label mbs still held at period end | ||||||||||||
private-label mbs sold during the period | ||||||||||||
pledged with agency mbs: | ||||||||||||
repurchase agreements outstanding | 4,241,855 | |||||||||||
agency mbs collateral, at fair value | 4,497,184 | |||||||||||
net amount | 255,329 | |||||||||||
weighted-average rate | 1.03 | |||||||||||
weighted-average term to maturity | 11,800 | |||||||||||
net amount represents the value of collateral in excess of corresponding repurchase obligation. the amount of collateral at-risk is limited to the outstanding repurchase obligation and not the entire collateral balance. | ||||||||||||
weighted-average outstanding balance during the three months ended | ||||||||||||
weighted-average rate during the three months ended | ||||||||||||
outstanding principal | 35,300,000 | |||||||||||
annual interest rate | 6,750 | |||||||||||
interest payment frequency | ||||||||||||
weighted-average interest rate | 6,750 | |||||||||||
maturity | ||||||||||||
early redemption date | ||||||||||||
interest rate swaps | 11,000 | |||||||||||
options on 10-year u.s. treasury note futures | 1,625,000 | |||||||||||
tba and specified agency mbs commitments | 3,910,000 | |||||||||||
years to maturity: | ||||||||||||
less than 3 years | 1,100,000,000 | |||||||||||
3 to less than 7 years | 125,000,000 | |||||||||||
7 to 10 years | 2,000,000,000 | |||||||||||
total / weighted-average | 3,225,000,000 | |||||||||||
effective in september / october 2017 | 375,000,000 | |||||||||||
purchased put options: | ||||||||||||
may 2017 expiration | 700,000,000 | |||||||||||
sold call options: | ||||||||||||
april 2017 expiration | -250,000,000 | |||||||||||
total / weighted-average for sold call options | -350,000,000 | |||||||||||
purchased call options: | ||||||||||||
january 2017 expiration | 950,000,000 | |||||||||||
february 2017 expiration | 700,000,000 | |||||||||||
total / weighted-average for purchased put options | 1,650,000,000 | |||||||||||
dollar roll positions: | ||||||||||||
4.0% coupon purchase commitments | 500,000,000 | |||||||||||
4.0% coupon sale commitments | -50,000,000 | |||||||||||
total tba commitments | 450,000,000 | |||||||||||
3.0% coupon purchase commitments | 725,000,000 | |||||||||||
3.5% coupon purchase commitments | 25,000,000 | |||||||||||
3.5% coupon sale commitments | -25,000,000 | |||||||||||
total dollar roll positions | 725,000,000 | |||||||||||
tba commitments serving as economic hedges: | ||||||||||||
total economic hedges | ||||||||||||
interest rate derivatives: | ||||||||||||
interest rate swaps: | ||||||||||||
net interest expense | -5,409,000 | |||||||||||
unrealized gains | 8,167,000 | |||||||||||
gains realized upon early termination | 631,000 | |||||||||||
total interest rate swap gains | 3,389,000 | |||||||||||
u.s. treasury note futures | 135,000 | |||||||||||
options on u.s. treasury note futures | -4,417,000 | |||||||||||
other | 62,000 | 109,000 | 179,000 | 110,000 | 113,000 | 76,000 | 62,000 | 21,000 | 82,000 | |||
total interest rate derivative losses | -893,000 | |||||||||||
tba and specified agency mbs commitments: | ||||||||||||
tba dollar roll income | 3,398,000 | |||||||||||
other gains on agency mbs commitments | -200,000 | |||||||||||
total gains on agency mbs commitments | 3,198,000 | |||||||||||
total derivative gains | 2,305,000 | |||||||||||
10-year u.s. treasury note futures | ||||||||||||
purchased put options on 10-year u.s. treasury note futures | 1,650,000,000 | |||||||||||
sold call options on 10-year u.s. treasury note futures | 1,000,000,000 | |||||||||||
purchased call options on 10-year u.s. treasury note futures | 1,000,000,000 | |||||||||||
commitments to purchase (sell) mbs | 725,000,000 | |||||||||||
put options on eurodollar futures | 4,000,000,000 | |||||||||||
cash collateral posted for: | ||||||||||||
tba commitments | ||||||||||||
total cash collateral posted | 63,782,000 | |||||||||||
cash collateral received for interest rate swaps | ||||||||||||
assets: | ||||||||||||
derivative instruments: | ||||||||||||
total derivative instruments | 5,546,000 | |||||||||||
total assets | 5,546,000 | |||||||||||
liabilities: | ||||||||||||
repurchase agreements | 4,241,855,000 | 7,183,000 | 6,604,000 | 6,125,000 | 2,863,000 | 763,000 | ||||||
total liabilities | 4,247,951,000 | |||||||||||
deposits | 72,516,000 | |||||||||||
does not include the fair value amount of financial instrument collateral pledged in respect of repurchase agreements that exceeds the associated liability presented in the consolidated balance sheets. | ||||||||||||
does not include the amount of cash collateral pledged in respect of derivative instruments that exceeds the associated derivative liability presented in the consolidated balance sheets. | ||||||||||||
level 1 inputs - | ||||||||||||
level 2 inputs - | ||||||||||||
level 3 inputs - | ||||||||||||
mbs | ||||||||||||
trading: | ||||||||||||
agency mbs | 4,391,274,000 | |||||||||||
private-label mbs | 1,292,000 | |||||||||||
total mbs | 4,392,566,000 | |||||||||||
derivative assets | 5,546,000 | |||||||||||
derivative liabilities | -6,096,000 | |||||||||||
other assets | 684,000 | |||||||||||
discount rate | 6,500 | |||||||||||
default rate | 2,250 | |||||||||||
loss severity rate | 45,000 | |||||||||||
total prepayment rate | 10,250 | |||||||||||
based on face value. | ||||||||||||
total net gains | ||||||||||||
included in investment gain | 162,000 | |||||||||||
included in other comprehensive income | ||||||||||||
purchases | ||||||||||||
payments | -22,000 | |||||||||||
accretion of discount | 37,000 | |||||||||||
net unrealized gains included in earnings for the period for level 3 assets still held at the reporting date | 162,000 | |||||||||||
basic weighted-average shares outstanding | 23,652,000 | |||||||||||
performance share units and unvested restricted stock | 245,000 | |||||||||||
diluted weighted-average shares outstanding | 23,897,000 | |||||||||||
net income | 5,254,000 | -6,613,000 | 4,868,000 | -2,218,000 | 3,431,000 | 307,000 | 7,241,000 | 22,868,000 | -17,928,000 | 18,813,000 | ||
yoy | 53.13% | -2254.07% | -52.62% | -98.66% | ||||||||
qoq | -179.45% | -235.85% | -319.48% | -164.65% | 1017.59% | -68.34% | -227.55% | -195.30% | ||||
basic earnings per common share | 220 | -260 | 150 | 100 | 260 | 860 | -740 | |||||
diluted earnings per common share | 220 | -260 | 150 | 100 | 260 | 850 | -740 | |||||
quarter ended | ||||||||||||
march 31 | 625 | |||||||||||
december 31 | 625 | |||||||||||
september 30 | 625 | |||||||||||
june 30 | 625 | |||||||||||
• | ||||||||||||
specified agency mbs | 4,391,274,000 | |||||||||||
inverse interest-only agency mbs | ||||||||||||
total agency mbs | 4,391,274,000 | |||||||||||
net long agency tba dollar roll positions | 472,430,000 | |||||||||||
total agency investment portfolio | 4,863,704,000 | |||||||||||
private-label interest-only mbs | 85,000 | |||||||||||
total private-label investment portfolio | 1,292,000 | |||||||||||
total mbs investment portfolio | 4,864,996,000 | |||||||||||
30-year fixed rate: | ||||||||||||
3.5% | 1,841,121,000 | |||||||||||
4.0% | 2,369,023,000 | |||||||||||
5.5% | 20,000 | |||||||||||
total/weighted-average | 4,210,164,000 | |||||||||||
fannie mae | 2,559,341,000 | |||||||||||
freddie mac | 1,650,823,000 | |||||||||||
30-year 4.0% coupon purchase commitments | 500,000,000 | |||||||||||
30-year 4.0% coupon sale commitments | -50,000,000 | |||||||||||
total net long agency tba dollar roll positions | 450,000,000 | |||||||||||
“notional amount” represents the unpaid principal balance of the underlying agency mbs. | ||||||||||||
“implied cost basis” represents the contractual forward price for the underlying agency mbs. | ||||||||||||
“implied fair value” represents the current fair value of the underlying agency mbs. | ||||||||||||
“net carrying amount” represents the difference between the implied cost basis and the current fair value of the underlying mbs. this amount is reflected on the company’s consolidated balance sheets as a component of “derivative assets, at fair value” and “derivative liabilities, at fair value.” | ||||||||||||
face amount | ||||||||||||
2,110 | ||||||||||||
the implied strike rate is estimated based upon the weighted-average strike price per option contract and the price of an equivalent 10-year u.s. treasury note futures contract. | ||||||||||||
interest income | 30,343,000 | |||||||||||
interest expense | 10,066,000 | |||||||||||
net interest income | 20,277,000 | 15,657,000 | 14,867,000 | 18,933,000 | 18,264,000 | |||||||
investment loss | -1,762,000 | |||||||||||
general and administrative expenses | 4,925,000 | |||||||||||
income before income taxes | 13,590,000 | -6,414,000 | 6,255,000 | -2,109,000 | 4,505,000 | 1,109,000 | 20,948,000 | 23,691,000 | -1,191,000 | 34,356,000 | ||
income tax benefit | 8,336,000 | 802,000 | 16,737,000 | |||||||||
diluted earnings per share | 0.22 | 0.81 | ||||||||||
weighted-average diluted shares outstanding | 23,897 | |||||||||||
short-term secured debt | 3,925,011 | 13,727,000 | 12,748,000 | 11,314,000 | ||||||||
net interest income/spread | ||||||||||||
net interest margin | ||||||||||||
mbs: | ||||||||||||
net long tba position | 554,846 | |||||||||||
total agency mbs portfolio | 4,806,261 | |||||||||||
gaap interest income | 30,343 | |||||||||||
gaap interest income plus tba dollar roll income | 33,741 | |||||||||||
interest expense on short-term debt | 8,859 | |||||||||||
net interest income plus tba dollar roll income | 24,882 | |||||||||||
tba dollar roll income is net of implied financing costs. | ||||||||||||
otti charges on available-for-sale securities | ||||||||||||
gains on trading investments | -4,219 | |||||||||||
tba and specified agency mbs commitments, net: | ||||||||||||
other gains from tba and specified agency mbs commitments | -200 | |||||||||||
total gains on tba and specified agency mbs commitments | 3,198 | |||||||||||
net interest expense on interest rate swaps | -5,409 | |||||||||||
other gains from interest rate derivative instruments | 4,516 | |||||||||||
total losses on interest rate derivatives | -893 | |||||||||||
gaap net interest income | 20,277 | |||||||||||
interest rate swap net interest expense | -5,409 | |||||||||||
economic net interest income | 18,266 | |||||||||||
core general and administrative expenses | -4,024 | |||||||||||
non-gaap core operating income | 14,242 | |||||||||||
non-gaap core operating income per diluted share | 0.6 | |||||||||||
gaap income before income taxes | 13,590 | |||||||||||
less: | ||||||||||||
total investment loss | 1,762 | -15,970,000 | ||||||||||
stock-based compensation expense | 901 | |||||||||||
non-recurring proxy contest related expenses | ||||||||||||
add back: | ||||||||||||
maximum amount outstanding at any month-end during the period | 4,241,855 | |||||||||||
north america | 12 | |||||||||||
europe | 1 | |||||||||||
asia | 3 | |||||||||||
stockholders’ equity | 374,481 | |||||||||||
book value per share | 15.83 | |||||||||||
exhibit number | ||||||||||||
3.01 | ||||||||||||
3.02 | ||||||||||||
3.03 | ||||||||||||
3.04 | ||||||||||||
4.01 | ||||||||||||
4.02 | ||||||||||||
4.03 | ||||||||||||
4.04 | ||||||||||||
4.05 | ||||||||||||
4.06 | ||||||||||||
4.07 | ||||||||||||
4.08 | ||||||||||||
4.09 | ||||||||||||
4.10 | ||||||||||||
4.11 | ||||||||||||
10.01 | ||||||||||||
10.02 | ||||||||||||
10.03 | ||||||||||||
10.04 | ||||||||||||
12.01 | ||||||||||||
31.01 | ||||||||||||
31.02 | ||||||||||||
32.01 | ||||||||||||
32.02 | ||||||||||||
101.ins | ||||||||||||
101.sch | ||||||||||||
101.cal | ||||||||||||
101.lab | ||||||||||||
101.pre | ||||||||||||
101.def | ||||||||||||
* | ||||||||||||
** | ||||||||||||
*** | ||||||||||||
arlington asset investment corp. | ||||||||||||
by: | ||||||||||||
date: may 1, 2017 | ||||||||||||
msr financing receivables | 5,247,000 | 4,709,000 | 4,685,000 | 3,608,000 | 3,983,000 | |||||||
agency mortgage-backed securities | 5,417,000 | 5,040,000 | 4,976,000 | 3,631,000 | 2,065,000 | 30,514,000 | 28,771,000 | 31,397,000 | 23,917,000 | |||
credit securities and loans | 2,849,000 | 2,802,000 | 2,762,000 | 2,736,000 | 991,000 | |||||||
mortgage loans of consolidated vies | 56,000 | 1,398,000 | 2,303,000 | 1,611,000 | ||||||||
total interest and other income | 13,575,000 | 12,716,000 | 14,000,000 | 12,388,000 | 8,763,000 | |||||||
rent revenues from single-family properties | 2,103,000 | 2,137,000 | ||||||||||
long-term debt secured by single-family properties | 741,000 | 718,000 | ||||||||||
long-term unsecured debt | 1,576,000 | 1,561,000 | 1,541,000 | 1,456,000 | 1,400,000 | 1,225,000 | 1,220,000 | 1,214,000 | ||||
secured debt of consolidated vies | 681,000 | 912,000 | 1,578,000 | |||||||||
total interest expense | 8,759,000 | 8,165,000 | 8,347,000 | 5,972,000 | 4,459,000 | 14,952,000 | 13,968,000 | 12,528,000 | 7,390,000 | |||
single-family property operating expenses | 1,872,000 | 1,915,000 | ||||||||||
net operating income | 4,816,000 | 4,551,000 | 5,653,000 | 6,647,000 | 4,526,000 | |||||||
investment and derivative gain | -7,997,000 | 6,417,000 | 1,235,000 | 370,000 | ||||||||
compensation and benefits | 2,091,000 | 2,037,000 | 2,255,000 | 2,256,000 | 2,324,000 | 3,505,000 | 3,449,000 | 2,804,000 | 3,430,000 | |||
other general and administrative expenses | 1,142,000 | 2,676,000 | 1,656,000 | 1,121,000 | 1,463,000 | 1,442,000 | 1,095,000 | 1,350,000 | 1,200,000 | |||
total general and administrative expenses | 3,233,000 | 4,713,000 | 3,911,000 | 3,377,000 | 3,787,000 | 4,947,000 | 4,544,000 | 4,154,000 | 4,630,000 | |||
income tax provision | 199,000 | 1,387,000 | 109,000 | 1,074,000 | 13,707,000 | 823,000 | 15,543,000 | |||||
dividend on preferred stock | -660,000 | -660,000 | -660,000 | -675,000 | -707,000 | -133,000 | -83,000 | -35,000 | ||||
net income (attributable) available to common stock | -7,273,000 | -17,963,000 | ||||||||||
weighted-average common shares outstanding | ||||||||||||
basic | 28,081,000 | 28,081,000 | 28,004,000 | 28,338,000 | 28,766,000 | 25,649,000 | 26,377,000 | 24,319,000 | 23,038 | |||
diluted | 28,081,000 | 28,709,000 | 28,004,000 | 28,913,000 | 28,766,000 | 26,011,000 | 26,856,000 | 24,319,000 | 23,349 | |||
net income available (attributable) to common stock | 4,208,000 | 2,756,000 | ||||||||||
investment and derivative loss | -3,851,000 | |||||||||||
net income attributable to common stock | -2,878,000 | -400,000 | ||||||||||
basic loss per common share | -100 | -10 | ||||||||||
diluted loss per common share | -100 | -10 | ||||||||||
private-label mortgage-backed securities | 19,000 | 2,000 | 43,000 | 1,655,000 | ||||||||
total interest income | 30,609,000 | 28,835,000 | 31,461,000 | 25,654,000 | ||||||||
investment gain | ||||||||||||
gain on trading investments | -23,208,000 | 13,996,000 | 15,855,000 | 2,468,000 | ||||||||
gain from derivative instruments | 33,169,000 | -572,000 | 15,196,000 | |||||||||
realized gain on sale of available-for-sale investments | 2,439,000 | |||||||||||
other-than-temporary impairment charges | ||||||||||||
total investment gain | 10,238,000 | 13,368,000 | 20,722,000 | |||||||||
net income available to common stock | 10,076,000 | 22,785,000 | ||||||||||
other comprehensive income, net of taxes | ||||||||||||
unrealized losses on available-for-sale securities | -221 | |||||||||||
reclassification | ||||||||||||
included in investment gain, net, related to sales of available-for-sale securities | ||||||||||||
included in investment gain, net, related to other-than-temporary impairment charges on available-for-sale securities | ||||||||||||
comprehensive income | 7,241,000 | 22,868,000 | -17,928,000 | 16,268 | ||||||||
realized loss on sale of available-for-sale investments | ||||||||||||
income from derivative instruments | -31,678,000 | |||||||||||
included in investment loss, net, related to sales of available-for-sale securities | ||||||||||||
included in investment loss, net, related to other-than- temporary impairment charges on available-for-sale securities | ||||||||||||
short-term debt | 6,193,000 | |||||||||||
long-term debt | 1,197,000 | |||||||||||
basic earnings per share | 0.82 | |||||||||||
weighted-average shares outstanding | ||||||||||||
basic | 28,081,000 | 28,081,000 | 28,004,000 | 28,338,000 | 28,766,000 | 25,649,000 | 26,377,000 | 24,319,000 | 23,038 | |||
diluted | 28,081,000 | 28,709,000 | 28,004,000 | 28,913,000 | 28,766,000 | 26,011,000 | 26,856,000 | 24,319,000 | 23,349 | |||
included in investment gain, net, related to sales of available- for-sale securities | -2,324 | |||||||||||
included in investment gain, net, related to other-than- temporary impairment charges on available-for-sale securities |